The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
Open accessAbstract
BACKGROUND: The long-term effects of treatment with sirolimus-eluting stents, as compared with bare-metal stents, have not been established. METHODS: We performed an analysis of individual data on 4958 patients enrolled in 14 randomized trials comparing sirolimus-eluting stents with bare-metal stents (mean follow-up interval, 12.1 to 58.9 months). The primary end point was death from any cause. Other outcomes were stent thrombosis, the composite end point of death or myocardial infarction, and the composite of death, myocardial infarction, or reintervention. RESULTS: The overall risk of death (hazard ratio, 1.03; 95% confidence interval [CI], 0.80 to 1.30) and the combined risk of death or myocardial infarction (hazard ratio, 0.97; 95% CI, 0.81 to 1.16) were not significantly different for patients receiving sirolimus-eluting stents versus bare-metal stents. There was a significant reduction in the combined risk of death, myocardial infarction, or reintervention (hazard ratio, 0.43; 95% CI, 0.34 to 0.54) associated with the use of sirolimus-eluting stents. There was no significant difference in the overall risk of stent thrombosis with sirolimus-eluting stents versus bare-metal stents (hazard ratio, 1.09; 95% CI, 0.64 to 1.86). However, there was evidence of a slight increase in the risk of stent thrombosis associated with sirolimus-eluting stents after the first year. CONCLUSIONS: The use of sirolimus-eluting stents does not have a significant effect on overall long-term survival and survival free of myocardial infarction, as compared with bare-metal stents. There is a sustained reduction in the need for reintervention after the use of sirolimus-eluting stents. The risk of stent thrombosis is at least as great as that seen with bare-metal stents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Morice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Self-citationSchofer, J., Schlüter, M., Gershlick, A. H., Wijns, W., Garcia, E., Schampaert, E., & Breithardt, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14462-5 · Cited by 955
Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation
Eisenstein, E. L., Anstrom, K. J., Kong, D. F., Shaw, L. K., Tuttle, R. H., Mark, D. B., Kramer, J. M., Harrington, R. A., Matchar, D. B., Kandzari, D. E., et al. (2007) · JAMA · doi:10.1001/jama.297.2.joc60179 · Cited by 870
Meta-analysis of the literature or of individual patient data: is there a difference?
Stewart, L. A., & Parmar, M. K. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)93004-k · Cited by 769
Systematic reviews of evaluations of prognostic variables
Altman, D. G. (2001) · BMJ · doi:10.1136/bmj.323.7306.224 · Cited by 756
Catastrophic outcomes of noncardiac surgery soon after coronary stenting
Kałuza, G. L., Joseph, J., Lee, J. R., Raizner, M. E., & Raizner, A. E. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00521-0 · Cited by 723
A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents
Babapulle, M. N., Joseph, L., Bélisle, P., Brophy, J. M., & Eisenberg, M. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16850-5 · Cited by 645
Schampaert, E., Cohen, E. A., Schlüter, M., Reeves, F., Traboulsi, M., Title, L. M., Kuntz, R. E., & Popma, J. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.01.024 · Cited by 575
Stewart, L. A., & Tierney, J. F. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702025001006 · Cited by 571
Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction
Spaulding, C., Henry, P., Teiger, E., Beatt, K., Bramucci, E., Carrié, D., Slama, M. S., Merkely, B., Erglis, A., Margheri, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062006 · Cited by 564
Simmonds, M. C., Higginsa, J. P. T., Stewartb, L. A., Tierneyb, J. F., Clarke, M. J., & Thompson, S. G. (2005) · Clinical Trials · doi:10.1191/1740774505cn087oa · Cited by 555
Moreno, R., Fernández, C., Hernández, R., Alfonso, F., Angiolillo, D. J., Sabaté, M., Escaned, J., Bañuelos, C., Fernández-Ortiz, A., & Macaya, C. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.065 · Cited by 544
Self-citationDiabetes mellitus and the clinical and angiographic outcome after coronary stent placement
Elezi, S., Kastrati, A., Pache, J., Wehinger, A., Hadamitzky, M., Dirschinger, J., Neumann, F.-J., & Schömig, A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00467-7 · Cited by 495
Self-citationLate Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical Trials
Bavry, A. A., Kumbhani, D. J., Helton, T. J., Borek, P. P., Mood, G. R., & Bhatt, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.023 · Cited by 490
Nordmann, A. J., Briel, M., & Bucher, H. C. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl282 · Cited by 480
Ho, P. M. (2008) · JAMA · doi:10.1001/jama.299.5.532 · Cited by 391
Sabaté, M., Jiménez-Quevedo, P., Angiolillo, D. J., Gómez-Hospital, J. A., Alfonso, F., Hernández-Antolín, R., Goicolea, J., Bañuelos, C., Escaned, J., Moreno, R., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.562421 · Cited by 368
Kaiser, C., Brunner-La Rocca, H. P., Buser, P. T., Bonetti, P. O., Osswald, S., Linka, A., Bernheim, A., Zutter, A., Zellweger, M., Grize, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67221-2 · Cited by 342
Self-citationSirolimus-eluting stents vs. standard stents in patients with stenosis in a native coronary artery
Moses, J. W., Leon, M. B., & Popma, J. J. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.10.042 · Cited by 324
Ardissino, D., Cavallini, C., Bramucci, E., Indolfi, C., Marzocchi, A., Manari, A., Angeloni, G., Carosio, G., Bonizzoni, E., Colusso, S., et al. (2004) · JAMA · doi:10.1001/jama.292.22.2727 · Cited by 314
Valgimigli, M., Percoco, G., Malagutti, P., Campo, G., Ferrari, F., Barbieri, D., Cicchitelli, G., McFadden, E. P., Merlini, F., Ansani, L., et al. (2005) · JAMA · doi:10.1001/jama.293.17.2109 · Cited by 307
Self-citationVermeersch, P., Agostoni, P., Verheye, S., Van den Heuvel, P., Convens, C., Bruining, N., Van den Branden, F., & Van Langenhove, G. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.021 · Cited by 256
Suttorp, M. J., Laarman, G. J., Rahel, B. M., Kelder, J. C., Bosschaert, M. A. R., Kiemeneij, F., ten Berg, J. M., Bal, E. T., Rensing, B. J., Eefting, F. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.613588 · Cited by 228
Self-citationTrading Restenosis for Thrombosis? New Questions about Drug-Eluting Stents
Shuchman, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068234 · Cited by 134
The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) Trial
Kelbæk, H., Thuesen, L., Helqvist, S., Kløvgaard, L., Jørgensen, E. O., Aljabbari, S., Saunamäki, K. I., Krusell, L. R., Jensen, G. V. H., Bøtker, H. E., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.045 · Cited by 115
Self-citationMeta-analysis comparing drug-eluting stents with bare metal stents
Katritsis, D. G., Karvouni, E., & Ioannidis, J. P. A. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.10.041 · Cited by 93
Indolfi, C., Pavía, M., & Angelillo, I. F. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.040 · Cited by 89
Effects of adjusting for censoring on meta-analyses of time-to-event outcomes
Vale, C. L., Tierney, J. F., & Stewart, L. A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.107 · Cited by 45
Ardissino, D., Cavallini, C., & Bramucci, E. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.02.035 · Cited by 39
Meta‐analyses using individual patient data
Clarke, M. J., & Stewart, L. A. (1997) · Journal of Evaluation in Clinical Practice · doi:10.1046/j.1365-2753.1997.00005.x · Cited by 24
Cited by
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Self-citationOptimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
Self-citationWriting Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
Metadata
- Authors
- Kastrati, A., Mehilli, J., Pache, J., Kaiser, C., Valgimigli, M., Kelbæk, H., Menichelli, M., Sabaté, M., Suttorp, M. J., Baumgart, D., Seyfarth, M., Pfisterer, M. E., & Schömig, A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-03-08
- Volume
- 356
- Issue
- 10
- Pages
- 1030-1039
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2106820552
- Cited by
- 1,006
- References
- 37
- FWCI
- 148.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.